First Dallas Securities Inc. Abbott Laboratories Transaction History

First Dallas Securities Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$102.07 - $123.37 $291,001 - $351,727	-2,851 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $45,493 - $55,476	-399 Reduced 12.28%	2,851 $337,000
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $23,106 - $28,292	200 Added 6.56%	3,250 $457,000
Q2 2021 Jul 06, 2021	SELL	$105.79 - $124.53 $483,989 - $569,724	-4,575 Reduced 60.0%	3,050 $354,000
Q4 2020 Feb 01, 2021	SELL	$105.0 - $114.42 $44,625 - $48,628	-425 Reduced 5.28%	7,625 $835,000
Q3 2020 Oct 15, 2020	SELL	$91.64 - $111.29 $9,164 - $11,129	-100 Reduced 1.23%	8,050 $876,000
Q1 2020 May 04, 2020	SELL	$62.82 - $91.86 $25,128 - $36,744	-400 Reduced 4.68%	8,150 $643,000
Q4 2019 Feb 04, 2020	BUY	$78.51 - $87.4 $137,392 - $152,950	1,750 Added 25.74%	8,550 $743,000
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $556,512 - $603,432	6,800 New	6,800 $569,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of First Dallas Securities Inc., based on Form 13F filings with the SEC.

Stay updated on First Dallas Securities Inc. with notifications on news.